{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:52:15Z","timestamp":1777467135994,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC1306604"],"award-info":[{"award-number":["2016YFC1306604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670216"],"award-info":[{"award-number":["81670216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873686"],"award-info":[{"award-number":["81873686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800219"],"award-info":[{"award-number":["81800219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2016JJ2166"],"award-info":[{"award-number":["2016JJ2166"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Health and Family Planning Commission of Hunan Province","award":["B20180760"],"award-info":[{"award-number":["B20180760"]}]},{"name":"Scientific Research Project of Health and Family Planning Commission of Hunan Province","award":["B20180729"],"award-info":[{"award-number":["B20180729"]}]},{"name":"the Foster Key Subject of the Third Xiangya Hospital of Central South University","award":["Clinical Laboratory Diagnostics"],"award-info":[{"award-number":["Clinical Laboratory Diagnostics"]}]},{"name":"the New Xiangya Talent Project of the Third Xiangya Hospital of Central South University","award":["20150301"],"award-info":[{"award-number":["20150301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00415-018-9125-z","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T05:26:36Z","timestamp":1542950796000},"page":"232-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-5454","authenticated-orcid":false,"given":"Kuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-0669","authenticated-orcid":false,"given":"Lamei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3240-4352","authenticated-orcid":false,"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"issue":"12","key":"9125_CR1","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10(12):1086\u20131097. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(11)70246-0","journal-title":"Lancet Neurol"},{"issue":"9","key":"9125_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","volume":"86","author":"Y Sekijima","year":"2015","unstructured":"Sekijima Y (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 86(9):1036\u20131043. \n                    https:\/\/doi.org\/10.1136\/jnnp-2014-308724","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"9125_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1212\/WNL.56.4.431","volume":"56","author":"E Hund","year":"2001","unstructured":"Hund E, Linke RP, Willig F, Grau A (2001) Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology 56(4):431\u2013435. \n                    https:\/\/doi.org\/10.1212\/WNL.56.4.431","journal-title":"Neurology"},{"issue":"6","key":"9125_CR4","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1007\/s12035-017-0694-0","volume":"55","author":"Q Chen","year":"2018","unstructured":"Chen Q, Yuan L, Deng X, Yang Z, Zhang S, Deng S, Lu H, Deng H (2018) A missense variant p.Ala117Ser in the transthyretin gene of a Han Chinese family with familial amyloid polyneuropathy. Mol Neurobiol 55(6):4911\u20134917. \n                    https:\/\/doi.org\/10.1007\/s12035-017-0694-0","journal-title":"Mol Neurobiol"},{"key":"9125_CR5","unstructured":"Sekijima Y, Yoshida K, Tokuda T, Ikeda S (1993) Familial transthyretin amyloidosis. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews. Seattle (WA). \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20301373"},{"issue":"11","key":"9125_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4593","volume":"14","author":"YS Eisele","year":"2015","unstructured":"Eisele YS, Monteiro C, Fearns C, Encalada SE, Wiseman RL, Powers ET, Kelly JW (2015) Targeting protein aggregation for the treatment of degenerative diseases. Nat Rev Drug Discov 14(11):759\u2013780. \n                    https:\/\/doi.org\/10.1038\/nrd4593","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9125_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0006-291X(83)80224-1","volume":"116","author":"S Tawara","year":"1983","unstructured":"Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S (1983) Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 116(3):880\u2013888. \n                    https:\/\/doi.org\/10.1016\/S0006-291X(83)80224-1","journal-title":"Biochem Biophys Res Commun"},{"key":"9125_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici L et al (2013) Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis 8:31. \n                    https:\/\/doi.org\/10.1186\/1750-1172-8-31","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"9125_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","volume":"29","author":"Y Parman","year":"2016","unstructured":"Parman Y, Adams D, Obici L, Gal\u00e1n L, Guergueltcheva V, Suhr OB, Coelho T (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol 29(Suppl 1):S3\u2013S13. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000288","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"9125_CR10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1212\/WNL.47.6.1562","volume":"47","author":"F Garzuly","year":"1996","unstructured":"Garzuly F, Vidal R, Wisniewski T, Brittig F, Budka H (1996) Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 47(6):1562\u20131567. \n                    https:\/\/doi.org\/10.1212\/WNL.47.6.1562","journal-title":"Neurology"},{"issue":"2","key":"9125_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","volume":"86","author":"LF Maia","year":"2015","unstructured":"Maia LF, Magalh\u00e3es R, Freitas J, Taipa R, Pires MM, Os\u00f3rio H, Dias D, Pessegueiro H et al (2015) CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. J Neurol Neurosurg Psychiatry 86(2):159\u2013167. \n                    https:\/\/doi.org\/10.1136\/jnnp-2014-308107","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"9125_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/01.wnl.0000178983.20975.af","volume":"65","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Yamashita T, Ueda M, Obayashi K, Sato T, Ikeda T, Washimi Y, Hirai T et al (2005) Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology 65(7):1051\u20131056. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000178983.20975.af","journal-title":"Neurology"},{"issue":"10","key":"9125_CR13","doi-asserted-by":"publisher","first-page":"2907.e11","DOI":"10.1016\/j.neurobiolaging.2015.06.019","volume":"36","author":"L Yuan","year":"2015","unstructured":"Yuan L, Deng X, Song Z, Yang Z, Ni B, Chen Y, Deng H (2015) Genetic analysis of the RAB39B gene in Chinese Han patients with Parkinson\u2019s disease. Neurobiol Aging 36(10):2907.e11\u20132907.e12. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.06.019","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9125_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/13506120500352404","volume":"12","author":"S Mitsuhashi","year":"2005","unstructured":"Mitsuhashi S, Yazaki M, Tokuda T, Sekijima Y, Washimi Y, Shimizu Y, Ando Y, Benson MD et al (2005) Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis. Amyloid 12(4):216\u2013225. \n                    https:\/\/doi.org\/10.1080\/13506120500352404","journal-title":"Amyloid"},{"issue":"5","key":"9125_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. \n                    https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"1","key":"9125_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","volume":"121","author":"Y Sekijima","year":"2005","unstructured":"Sekijima Y, Wiseman RL, Matteson J, Hammarstr\u00f6m P, Miller SR, Sawkar AR, Balch WE, Kelly JW (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121(1):73\u201385. \n                    https:\/\/doi.org\/10.1016\/j.cell.2005.01.018","journal-title":"Cell"},{"issue":"10","key":"9125_CR17","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/jnnp.2003.029942","volume":"75","author":"K Jin","year":"2004","unstructured":"Jin K, Sato S, Takahashi T, Nakazaki H, Date Y, Nakazato M, Tominaga T, Itoyama Y et al (2004) Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 75(10):1463\u20131466. \n                    https:\/\/doi.org\/10.1136\/jnnp.2003.029942","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9125_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jocn.2015.12.017","volume":"29","author":"MB Bevers","year":"2016","unstructured":"Bevers MB, McGuone D, Jerath NU, Musolino PL (2016) Leptomeningeal transthyretin-type amyloidosis presenting as acute hydrocephalus and subarachnoid hemorrhage. J Clin Neurosci 29:203\u2013205. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2015.12.017","journal-title":"J Clin Neurosci"},{"issue":"Pt2","key":"9125_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/brain\/122.2.183","volume":"122","author":"M Brett","year":"1999","unstructured":"Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE, Hawkins PN, Pepys MB et al (1999) Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 122(Pt2):183\u2013190. \n                    https:\/\/doi.org\/10.1093\/brain\/122.2.183","journal-title":"Brain"},{"issue":"3","key":"9125_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/lt.21996","volume":"16","author":"AP Barreiros","year":"2010","unstructured":"Barreiros AP, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Sch\u00e4fers HJ, Galle PR, Otto G (2010) Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience. Liver Transpl 16(3):314\u2013323. \n                    https:\/\/doi.org\/10.1002\/lt.21996","journal-title":"Liver Transpl"},{"issue":"1","key":"9125_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00415-014-7594-2","volume":"262","author":"P McColgan","year":"2015","unstructured":"McColgan P, Viegas S, Gandhi S, Bull K, Tudor R, Sheikh F, Pinney J, Fontana M et al (2015) Oculoleptomeningeal amyloidosis associated with transthyretin Leu12Pro in an African patient. J Neurol 262(1):228\u2013234. \n                    https:\/\/doi.org\/10.1007\/s00415-014-7594-2","journal-title":"J Neurol"},{"issue":"1","key":"9125_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/13506120600551814","volume":"13","author":"Y Shimizu","year":"2006","unstructured":"Shimizu Y, Takeuchi M, Matsumura M, Tokuda T, Iwata M (2006) A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation. Amyloid 13(1):37\u201341. \n                    https:\/\/doi.org\/10.1080\/13506120600551814","journal-title":"Amyloid"},{"issue":"15","key":"9125_CR23","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1212\/WNL.0b013e3181a0fe74","volume":"72","author":"K Hagiwara","year":"2009","unstructured":"Hagiwara K, Ochi H, Suzuki S, Shimizu Y, Tokuda T, Murai H, Shigeto H, Ohyagi Y et al (2009) Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr. Neurology 72(15):1358\u20131360. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181a0fe74","journal-title":"Neurology"},{"issue":"6","key":"9125_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.nrl.2012.12.006","volume":"29","author":"L Llull","year":"2014","unstructured":"Llull L, Berenguer J, Yag\u00fce J, Graus F (2014) Leptomeningeal amyloidosis due to A25T TTR mutation: a case report. Neurologia 29(6):382\u2013384. \n                    https:\/\/doi.org\/10.1016\/j.nrl.2012.12.006","journal-title":"Neurologia"},{"issue":"4","key":"9125_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/WNL.47.4.988","volume":"47","author":"MK Herrick","year":"1996","unstructured":"Herrick MK, DeBruyne K, Horoupian DS, Skare J, Vanefsky MA, Ong T (1996) Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47(4):988\u2013992. \n                    https:\/\/doi.org\/10.1212\/WNL.47.4.988","journal-title":"Neurology"},{"issue":"1","key":"9125_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1212\/01.wnl.0000250343.34110.79","volume":"68","author":"JD Dowell","year":"2007","unstructured":"Dowell JD, Fleck JD, Vakili ST, Benson MD (2007) Familial oculoleptomeningeal amyloidosis associated with primary angiitis of the CNS. Neurology 68(1):77\u201378. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000250343.34110.79","journal-title":"Neurology"},{"issue":"3","key":"9125_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/brain\/103.3.473","volume":"103","author":"H Goren","year":"1980","unstructured":"Goren H, Steinberg MC, Farboody GH (1980) Familial oculoleptomeningeal amyloidosis. Brain 103(3):473\u2013495. \n                    https:\/\/doi.org\/10.1093\/brain\/103.3.473","journal-title":"Brain"},{"issue":"3","key":"9125_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ana.410410305","volume":"41","author":"RB Petersen","year":"1997","unstructured":"Petersen RB, Goren H, Cohen M, Richardson SL, Tresser N, Lynn A, Gali M, Estes M et al (1997) Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 41(3):307\u2013313. \n                    https:\/\/doi.org\/10.1002\/ana.410410305","journal-title":"Ann Neurol"},{"issue":"11","key":"9125_CR29","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ophtha.2007.07.007","volume":"114","author":"RH Roe","year":"2007","unstructured":"Roe RH, Fisher Y, Eagle RC, Fine HF, Cunningham ET (2007) Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Ophthalmology 114(11):e33\u2013e37. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2007.07.007","journal-title":"Ophthalmology"},{"issue":"4","key":"9125_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jocn.2014.10.021","volume":"22","author":"JK Liu","year":"2015","unstructured":"Liu JK, Turner RD, Luciano MG, Krishnaney AA (2015) Circumferential intrathecal ossification in oculoleptomeningeal amyloidosis. J Clin Neurosci 22(4):769\u2013771. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2014.10.021","journal-title":"J Clin Neurosci"},{"issue":"5","key":"9125_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.humpath.2013.10.037","volume":"45","author":"SE Martin","year":"2014","unstructured":"Martin SE, Benson MD, Hattab EM (2014) The pathologic spectrum of oculoleptomeningeal amyloidosis with Val30Gly transthyretin gene mutation in a postmortem case. Hum Pathol 45(5):1105\u20131108. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2013.10.037","journal-title":"Hum Pathol"},{"issue":"7","key":"9125_CR32","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1212\/WNL.53.7.1498","volume":"53","author":"M Mascalchi","year":"1999","unstructured":"Mascalchi M, Salvi F, Pirini MG, D\u2019Errico A, Ferlini A, Lolli F, Plasmati R, Tessa C et al (1999) Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 53(7):1498\u20131503. \n                    https:\/\/doi.org\/10.1212\/WNL.53.7.1498","journal-title":"Neurology"},{"issue":"5","key":"9125_CR33","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1212\/WNL.51.5.1462","volume":"51","author":"CJ Klein","year":"1998","unstructured":"Klein CJ, Nakumura M, Jacobson DR, Lacy MQ, Benson MD, Petersen RC (1998) Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology 51(5):1462\u20131464. \n                    https:\/\/doi.org\/10.1212\/WNL.51.5.1462","journal-title":"Neurology"},{"issue":"1\u20132","key":"9125_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jns.2008.05.014","volume":"272","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, Sheikh SI, Snuderl M, Frosch MP, Greenberg SM (2008) A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci 272(1\u20132):186\u2013190. \n                    https:\/\/doi.org\/10.1016\/j.jns.2008.05.014","journal-title":"J Neurol Sci"},{"issue":"1","key":"9125_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1212\/WNL.57.1.135","volume":"57","author":"E Ellie","year":"2001","unstructured":"Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S (2001) Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 57(1):135\u2013137. \n                    https:\/\/doi.org\/10.1212\/WNL.57.1.135","journal-title":"Neurology"},{"issue":"2","key":"9125_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2006.093500","volume":"78","author":"C Douglass","year":"2007","unstructured":"Douglass C, Suvarna K, Reilly MM, Hawkins PN, Hadjivassiliou M (2007) A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia. J Neurol Neurosurg Psychiatry 78(2):193\u2013195. \n                    https:\/\/doi.org\/10.1136\/jnnp.2006.093500","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"9125_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/13506129.2011.574354060","volume":"18","author":"JJ Liepnieks","year":"2011","unstructured":"Liepnieks JJ, Dickson DW, Benson MD (2011) A new transthyretin mutation associated with leptomeningeal amyloidosis. Amyloid 18(Suppl 1):160\u2013162. \n                    https:\/\/doi.org\/10.3109\/13506129.2011.574354060","journal-title":"Amyloid"},{"issue":"10","key":"9125_CR38","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/archneur.1988.00520340072015","volume":"45","author":"RJ Uitti","year":"1988","unstructured":"Uitti RJ, Donat JR, Rozdilsky B, Schneider RJ, Koeppen AH (1988) Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol 45(10):1118\u20131122. \n                    https:\/\/doi.org\/10.1001\/archneur.1988.00520340072015","journal-title":"Arch Neurol"},{"issue":"9","key":"9125_CR39","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/archneur.56.9.1152","volume":"56","author":"T Uemichi","year":"1999","unstructured":"Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD (1999) Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 56(9):1152\u20131155. \n                    https:\/\/doi.org\/10.1001\/archneur.56.9.1152","journal-title":"Arch Neurol"},{"issue":"10","key":"9125_CR40","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1212\/01.WNL.0000065901.18353.AB","volume":"60","author":"G Blevins","year":"2003","unstructured":"Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson MD et al (2003) Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 60(10):1625\u20131630. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000065901.18353.AB","journal-title":"Neurology"},{"issue":"3","key":"9125_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3129\/i09-023","volume":"44","author":"K Schweitzer","year":"2009","unstructured":"Schweitzer K, Ehmann D, Garcia R, Alport E (2009) Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His. Can J Ophthalmol 44(3):317\u2013319. \n                    https:\/\/doi.org\/10.3129\/i09-023","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"9125_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/13506120903421587","volume":"16","author":"OB Suhr","year":"2009","unstructured":"Suhr OB, Andersen O, Aronsson T, Jonasson J, Kalimo H, Lundahl C, Lundgren HE, Melberg A et al (2009) Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden. Amyloid 16(4):208\u2013214. \n                    https:\/\/doi.org\/10.3109\/13506120903421587","journal-title":"Amyloid"},{"key":"9125_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40478-015-0216-0","volume":"3","author":"JL Ziskin","year":"2015","unstructured":"Ziskin JL, Greicius MD, Zhu W, Okumu AN, Adams CM, Plowey ED (2015) Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia. Acta Neuropathol Commun 3:43. \n                    https:\/\/doi.org\/10.1186\/s40478-015-0216-0","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"9125_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/13506129409148620","volume":"1","author":"SR Zeldenrust","year":"1994","unstructured":"Zeldenrust SR, Skinner M, Share J, Benson MD (1994) A new transthyretin variant (His 69) associated with vitreous amyloid in an FAP family. Amyloid 1(1):17\u201322. \n                    https:\/\/doi.org\/10.3109\/13506129409148620","journal-title":"Amyloid"},{"issue":"4","key":"9125_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/13506129.2013.829439","volume":"20","author":"JC Purrucker","year":"2013","unstructured":"Purrucker JC, Hund E, Hinderhofer K, Kollmer J, Sch\u00f6nland S, Hegenbart U (2013) Doxycycline in ATTRY69H (p.ATTRY89H) amyloidosis with predominant leptomeningeal manifestation. Amyloid 20(4):279\u2013280. \n                    https:\/\/doi.org\/10.3109\/13506129.2013.829439","journal-title":"Amyloid"},{"key":"9125_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.wneu.2017.12.096","volume":"111","author":"F Mathieu","year":"2018","unstructured":"Mathieu F, Morgan E, So J, Munoz DG, Mason W, Kongkham P (2018) Oculoleptomeningeal amyloidosis secondary to the rare transthyretin c.381T> G (p.Ile127Met) mutation. World Neurosurg 111:190\u2013193. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2017.12.096","journal-title":"World Neurosurg"},{"issue":"3","key":"9125_CR47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/13506120308998998","volume":"10","author":"LH Connors","year":"2003","unstructured":"Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE (2003) Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 10(3):160\u2013184. \n                    https:\/\/doi.org\/10.3109\/13506120308998998","journal-title":"Amyloid"},{"issue":"4","key":"9125_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mus.20821","volume":"36","author":"MD Benson","year":"2007","unstructured":"Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36(4):411\u2013423. \n                    https:\/\/doi.org\/10.1002\/mus.20821","journal-title":"Muscle Nerve"},{"issue":"Suppl 1","key":"9125_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/13506129.2012.682187","volume":"19","author":"F Salvi","year":"2012","unstructured":"Salvi F, Pastorelli F, Plasmati R, Bartolomei I, Dall\u2019Osso D, Rapezzi C (2012) Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis. Amyloid 19(Suppl 1):58\u201360. \n                    https:\/\/doi.org\/10.3109\/13506129.2012.682187","journal-title":"Amyloid"},{"issue":"1","key":"9125_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pjnns.2017.10.006","volume":"52","author":"A Stabile","year":"2018","unstructured":"Stabile A, Di Lazzaro V, Colosimo C, Piazza F, Ferrarese C, Di Francesco JC (2018) Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature. Neurol Neurochir Pol 52(1):102\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.pjnns.2017.10.006","journal-title":"Neurol Neurochir Pol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9125-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T19:13:10Z","timestamp":1574449990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9125-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["9125"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9125-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"assertion":[{"value":"12 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study received approval from the Ethics Committee of the Third Xiangya Hospital and was performed in accordance with the ethical standards stated in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from the individuals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}